|
|||||
|
|
Intensity-modulated radiation therapy and doxorubicin in thyroid cancer: A prospective phase 2 trial |
|
| Authors: | Paul B. Romesser MD Eric J. Sherman MD Karissa Whiting MS Margaret L. Ho MA Ashok R. Shaha MD Mona M. Sabra MD Nadeem Riaz MD MSc Todd E. Waldenberg BS Christopher R. Sabol BS Ian Ganly MD PhD Sean M. McBride MD MPH James A. Fagin MD Zhigang Zhang PhD R. Michael Tuttle MD Richard J. Wong MD Nancy Y. Lee MD |
| Affiliation: | 1. Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York;2. Head and Neck Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York;3. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York;4. Head and Neck Division, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York;5. Endocrinology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York |
| Abstract: | |
| Keywords: | chemoradiation head and neck cancer intensity-modulated radiation therapy (IMRT) radiation therapy thyroid cancer |